Animalcare gets New Year injection of good news

ANIMALCARE Group today said it had started the year in a “very good way” by resuming the sale of a pain relief product for dogs and cats.

The York-based veterinary medicines supplier lost its last supplier of Buprecare single dose ampoules in July 2011 after the contract manufacturing group Recipharm shut a production plant.

Now Animalcare says it has signed a new contract with a German multinational contract manufacturer to supply it with the Buprecare product for sale across the UK and Europe.

Animalcare’s management team said it was confident that thanks to the new supply it can achieve sales levels similar to those it previously achieved with its previous supplier.

The group said that a multidose Buprecare analgesic for cats and dogs launched in March last year continues to sell well and will complement the sale of the ampoule product.

Stephen Wildridge, chief executive of Animalcare, said:  “It was very disappointing to lose our marketing leading product Buprecare ampoules so abruptly however after some excellent work from the Animalcare team in identifying and working with a very competent manufacturer we are now back in a market that has been eagerly awaiting our return and with a supplier that puts us in an even stronger position.  It’s a very good way to start 2013.”